Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, HKEX: 02315), a global biotechnology company that drives the research and development of novel antibody-based drugs with innovative ...
(RTTNews) - Biocytogen Pharmaceuticals (Beijing) Co., Ltd. and Merck KGaA (MKKGY, MRCG.DE, MRK.MI) announced that they have entered into an evaluation and option agreement to advance the development ...
Its proprietary and differentiated lipid nanoparticle (LNP) platform is a cornerstone in advancing next-generation messenger ...
The MarketWatch News Department was not involved in the creation of this content. -- Key presentation unveiled Acuitas' Next-Generation LNP Advancements, which is designed to enhance potency and ...
Unlocking the therapeutic applicability of LNP-mRNA: chemistry, formulation, and clinical strategies
LNP as the novel drug delivery system enhancing mRNA therapeutic efficacy has been proved for its delivery ability. This review provides valuable insights into the current state-of-the-art of LNP mRNA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results